Despite a recent earnings miss, Charles Schwab's stock has significantly outpaced the market over the past year. Wall Street maintains a cautiously optimistic stance, with upgraded ratings and bullish price targets pointing to further potential gains.
As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.
Despite successful ballot initiatives in several states, the path to securing abortion access remains fraught with legal challenges and legislative pushback, as seen in ongoing battles from Missouri to Arizona.
A draft proposal from disaster response firm Gothams LLC, obtained by The Guardian, outlined terms for a trucking and logistics monopoly in Gaza that would guarantee extraordinary returns, raising questions about oversight and ethics in post-conflict rebuilding.
A 13-year-old boy's extraordinary four-hour swim to shore triggered a successful multi-agency rescue after his mother and two siblings were swept out to sea off Quindalup, with officials hailing the family's collective bravery.
Shares of USA Rare Earth (NASDAQ: USAR) climbed over 6% Monday morning following reports of a proposed U.S. government initiative, dubbed 'Project Vault,' aimed at securing a strategic reserve of critical minerals, including rare earths, to counter potential supply chain vulnerabilities.
As the U.S. renewable energy sector builds on a record-breaking 2025, it faces a critical juncture defined by supply chain pressures, extreme weather, and evolving market rules. Strategic adaptation, not just growth, will determine its sustainable trajectory.
Ukrainian President Volodymyr Zelenskiy stated on Monday that achieving a lasting and honorable peace is a realistic goal, as preparations finalize for a new round of negotiations involving Russian and U.S. officials set to begin this week in the UAE capital.
A damning report from the EU's financial watchdog reveals the bloc's struggle to secure the minerals essential for its climate goals, highlighting failed trade deals, stalled recycling, and persistent over-reliance on external suppliers.
Amidst market volatility, Microsoft's diversified empire—spanning cloud, AI, productivity, and gaming—positions it as a resilient long-term holding for investors looking beyond short-term fluctuations.
Once-coveted items, from vintage vinyl to limited-edition toys, are now gathering dust in attics and failing to sell online as market saturation and shifting tastes redefine what's truly collectible.
A fire erupted in a commercial building in Karachi on Monday, just weeks after a nearby inferno claimed dozens of lives. Firefighters are battling the flames as concerns mount over recurring safety lapses in the city's business districts.
Major financial institutions Barclays and Morgan Stanley maintain projections for two interest rate cuts in 2024, despite President Trump's nomination of inflation hawk Kevin Warsh to chair the Federal Reserve. Analysts suggest policy continuity in the near term, though Senate confirmation faces political hurdles.
H.C. Wainwright maintains a Buy rating on Lexeo Therapeutics but slashes its price target, citing persistent market doubts over the company's PKP2 cardiomyopathy program despite encouraging early clinical results.
Wall Street's top analysts made waves Monday with revised ratings on key stocks, highlighting a growing divergence in tech and retail outlooks as earnings season approaches.
Needham raises Nova Ltd. (NVMI) to Buy with a $500 price target, citing improving industry conditions and the company's strategic position in China's memory market. The upgrade follows a similar bullish move by Bank of America earlier in January.
Zions Bancorporation has authorized a new $75 million stock repurchase program, a move analysts see as a bet on its undervalued shares and a commitment to shareholder returns as regional banks navigate a cautious regulatory environment.
Despite a recent 4.7% stock decline, Edwards Lifesciences (NYSE: EW) boasts a robust 13% Return on Equity, outperforming its industry. Yet, its modest 4.6% five-year growth rate raises questions about future potential and market valuation.
Investment firm Ashva Capital Management highlights Advanced Micro Devices (AMD) in its latest investor letter, citing the chipmaker's disciplined execution as a cornerstone for enduring growth, even as the fund's overall 2025 returns trailed major indices.
Investment firm Ashva Capital Management reveals Micron Technology as its largest holding in its latest investor letter, detailing a conviction play on the memory chip giant's long-term trajectory amid AI-driven demand and market volatility.
